Averica Enters into Preferred Provider Agreement with Irix Pharmaceuticals

February 4, 2014

Averica’s Targeted IsolationTM Approach Results in Rapid Structure Elucidation of Impurities and Saves IRIX’s Clients Time and Money
 
MARLBOROUGH, MA, February 4, 2014 – Averica Discovery Services, Inc., a contract research organization (CRO) with specialized expertise in small molecule analysis and purification, today announced an expansion of its existing relationship with IRIX Pharmaceuticals, Inc., a leading small molecule contract research and manufacturing organization (CRMO) that helps innovative health care industry clients bring new drugs to market. Averica will provide services to IRIX on a preferred provider basis.
 
Averica Discovery Services supplies a wide variety of chromatography and analytical services to pharmaceutical, biotechnology and other life sciences researchers. Averica works with its clients to speed lead optimization and early development timelines. The company provides highly pure assay material and it has substantial expertise in the isolation and structure elucidation of impurities – a valuable asset for optimizing chemistry for production of clinical trial drug supplies.
 
“IRIX’s leading position as a supplier of active pharmaceutical ingredients to biotechnology firms and others reflects our scientific excellence, commitment to quality and record of on-time production,” commented J. Guy Steenrod, CEO of IRIX Pharmaceuticals. “Leveraging Averica’s capabilities early in the API development process allows our customers to benefit from the most advanced science available.  We are pleased to expand this relationship that has been valuable for both companies.” 
 
Averica developed its Targeted Isolation™ process for rapid and accurate isolation of unknown impurities in mixtures. Conventional chromatographic approaches can require weeks of effort to accumulate enough material for isolation and elucidation. Averica's Supercritical Fluid Chromatography (SFC) process is much more efficient and produces results in a fraction of the time.
 
“Our shared commitment to scientific excellence and outstanding customer service provides a strong rationale for extending our relationship with IRIX,” noted Jeffrey Kiplinger, PhD, president of Averica Discovery Services. “The reduction in timeline and costs delivered by our Targeted Isolation approach is a great example of how our services are helping innovative companies develop new medicines more efficiently.”
 
About Averica Discovery Services
Founded in 2007, Averica Discovery Services is a contract research organization with specialized expertise in small molecule analysis and purification.  Averica works with drug discovery and development teams to speed lead optimization and timelines in early development.  Its services include scalable compound supply, chiral resolution, pre-formulation and proprietary services such as Targeted Isolation™. Averica is located in the heart of the East Coast life sciences corridor, just west of Boston.
 
About IRIX Pharmaceuticals
IRIX Pharmaceuticals, Inc. is a science-driven small molecule contract research and manufacturing organization (CRMO) helping clients rapidly bring new drugs to market. U.S.-based IRIX is a fully-integrated active pharmaceutical ingredient (API) development and supply company with demonstrated scientific excellence and commitment to the success of its clients. Its services include preclinical and discovery support, process research and development, GLP toxicology, clinical supply, commercial production and manufacturing, stability studies and regulatory support. For more information, visit www.irixpharma.com.

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.